title: Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy.
authors.affiliation: Department of Medicine, University of Colorado Cancer Center and University of Colorado Health Sciences Center, Aurora, 80045, USA. paul.bunn@uchsc.edu
authors.forename: Paul A
authors.initials: PA
authors.lastname: Bunn
authors.forename: Rafal
authors.initials: R
authors.lastname: Dziadziuszko
authors.forename: Marileila
authors.initials: M
authors.lastname: Varella-Garcia
authors.forename: Wilbur A
authors.initials: WA
authors.lastname: Franklin
authors.forename: Samir E
authors.initials: SE
authors.lastname: Witta
authors.forename: Karen
authors.initials: K
authors.lastname: Kelly
authors.forename: Fred R
authors.initials: FR
authors.lastname: Hirsch
mesh_terms: D015415:Biomarkers / Q000032:analysis; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000503:physiopathology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D008175:Lung Neoplasms / Q000503:physiopathology* / Q000601:surgery / Q000628:therapy*; D010766:Phosphorylation; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D020893:Receptor, ErbB-3 / Q000378:metabolism
chemical_list: D015415:Biomarkers; D066246:ErbB Receptors; D018719:Erb-b2 Receptor Tyrosine Kinases; D020893:Receptor, ErbB-3